Skip to main content
. 2021 Oct 26;6:70. doi: 10.1038/s41536-021-00178-4

Fig. 4. Macrophages targeted nanomedicine.

Fig. 4

Macrophages of different phenotypes in inflamed tissues can be targeted by injecting specific nanoparticles. Drug-loaded NPs, such as chlorophosphate-containing liposomes, blocks HO formation by depleting macrophages. In addition, NPs loaded with siRNA can inhibit the recruitment of macrophages and the secretion of inflammatory mediators by downregulating the expression of CCR2 or CCR5, which may be a new approach for the prevention of HO.